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Abstract
Rai/ShcC is a member of the Shc family of protein adaptors expressed with the highest abundance in the central nervous
system, where it exerts a protective function by coupling neurotrophic receptors to the PI3K/Akt survival pathway. Rai is
also expressed, albeit at lower levels, in other cell types, including T and B lymphocytes. We have previously reported that in
these cells Rai attenuates antigen receptor signaling, thereby impairing not only cell proliferation but also, opposite to
neurons, cell survival. Here we have addressed the mechanism underlying the inhibitory activity of Rai on TCR signaling. We
show that Rai interferes with the TCR signaling cascade one of the earliest steps –recruitment of the initiating kinase ZAP-70
to the phosphorylated subunit of the TCR/CD3 complex, which results in a generalized dampening of the downstream
signaling events. The inhibitory activity of Rai is associated to its inducible recruitment to phosphorylated CD3, which occurs
in the physiological signaling context of the immune synapse. Rai is moreover found as a pre-assembled complex with ZAP-
70 and also constitutively interacts with the regulatory p85 subunit of PI3K, similar to neuronal cells, notwithstanding the
opposite biological outcome, i.e. impairment of PI-3K/Akt activation. The data highlight the ability of Rai to establish
interactions with the TCR and key signaling mediators which, either directly (e.g. by inhibiting ZAP-70 recruitment to the
TCR or sequestering ZAP-70/PI3K in the cytosol) or indirectly (e.g. by promoting the recruitment of effectors responsible for
signal extinction) prevent full triggering of the TCR signaling cascade.
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Introduction
Rai, also known as N-Shc/ShcC, belongs to the Shc family of
protein adaptors. This family includes four members which
collectively act as central participants in the signaling pathways
triggered by tyrosine kinase-coupled surface receptors controlling a
number of cellular processes, including proliferation, differentiation,
survival and motility [1]. As all Shc proteins, Rai has a modular
structure characterized by a central collagen homology (CH1)
domain containing five phosphorylatable tyrosine residues flanked
by a N-terminal PTB domain and a C-terminal SH2 domain [2,3].
Rai encodes two proteins, of 52 and 64 kDa respectively, which
are present at high levels in the CNS, with a selective expression in
post-mitotic and mature neurons. Expression of Rai in the CNS is
developmentally regulated, with a pattern opposite to ShcA.
During embryonic development Rai is absent in developing
neurons, where ShcA is instead highly expressed and promotes the
proliferation of neuronal stem cells. As neuronal progenitors
differentiate ShcA is progressively downregulated and replaced by
Rai, which reaches maximal levels in the adult brain [2–5].
Rai expression has been associated with differentiation and
survival of neuronal cells, where it couples tyrosine kinase
receptors such as Ret to the PI-3K/Akt survival pathway [6].
Rai promotes moreover sustained activation of MAP kinases,
thereby contributing to neuronal differentiation [6,7]. Of note, at
variance with ShcA, the latter activity does not involve recruitment
of Grb2/Sos complexes, as none of the phoshorylatable tyrosine
residues in the CH1 domain is a high affinity binding site for Grb2
[7]. The PI-3K/Akt dependent pro-survival function of Rai has
also been established in the pathological context of hypoxia and
oxidative stress, as demonstrated by the enhanced apoptotic
response of cortical neurons from Rai2/2 mice and the more
severe neurological damage and size of infarct area in a model of
brain ischemia/reperfusion injury [8]. More recently, Rai has
been implicated in retinal development and regeneration [9].
Moreover, ectopic or abnormal Rai expression has been associated
to some types of cancer, including aggressive neuroblastomas and
thyroid carcinomas [10–12].
While expression of Rai is restricted prevalently to neurons, Rai
is also expressed, albeit at lower levels, in other cell types, such as
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enteric glial cells, endothelial cells and smooth muscle cells of the
gastrointestinal tract [13], indicating potential functions of this
adaptor outside of the CNS. In support of this notion, we found
that the p52 kDa isoform of Rai is expressed in both T and B
lymphocytes. Interestingly, in these cells Rai antagonizes activa-
tion and survival pathways triggered by the antigen receptors, at
variance with its function in neurons. Rai2/2 mice display
pathological features consistent with this inhibitory function,
including splenomegaly, spontaneous T- and B-cell activation
and autoantibody production, which eventually lead to the
development of a lupus-like autoimmune disease [14].
While a function of Rai as a negative regulator of TCR and
BCR signaling has clearly emerged from this study, the
mechanism by which Rai modulates the respective signaling
cascades has as yet not been elucidated. Here we demonstrate that
Rai inhibits TCR signaling at one of the earliest steps in the
cascade, recruitment of ZAP-70 to the activated receptor, thereby
preventing productive downstream signaling.
Results
Rai dampens TCR signaling
To elucidate the mechanism underlying the inhibitory activity of
Rai on TCR signaling we initially used Jurkat T cells, which do not
express Rai at detectable levels, to generate a transfectant stably
expressing the p52 isoform of Rai. A Jurkat line stably transfected
with empty vector was used as control. Given the partial homology
of the PTB and SH2 domains among Shc family members, as
control of specificity we also generated similar transfectants using as
recipient the Jurkat variant JSL1, which is deficient for ShcA
expression [15]. The immunoblot analysis of Rai expression in the
Jurkat and JSL1 transfectants is shown in figure S1A.
The impact of Rai expression on TCR signaling was assessed by
immunoblot analysis of cell lysates with phosphospecific antibodies
which recognize the active forms of ZAP-70, Vav, Erk and JNK,
respectively. The activation of LAT was moreover assessed by
immunoblot analysis of LAT-specific immunoprecipitates with anti-
phosphotyrosine antibodies. As shown in figure 1A, activation of
ZAP-70, one of the earliest events in the TCR signaling cascade,
was significantly lower in Rai-expressing Jurkat cells compared to
control cells. In agreement with this result, Rai expression resulted
in impaired activation of the transmembrane adaptor LAT (Fig. 1B),
which couples the TCR to multiple signaling pathways [16], as well
as of Vav (Fig. 1C), a Rho family specific guanine nucleotide
exchanger which regulates the reorganization of cortical actin
required for the topological orchestration of the TCR signaling
cascade during immune synapse assembly [17]. Moreover,
consistent with the defect in LAT and Vav phosphorylation,
activation of Erk and JNK, which couple the TCR to gene
transcription downstream of Ras and Rho GTPases, respectively
[18,19], was found to be blunted in the presence of Rai (Fig. 1D,E).
In agreement with these findings and with our previous report
showing that Rai deficiency potentiates TCR dependent activation
of ZAP-70 and the MAP kinases in mouse T cells [14], Vav
phosphorylation was significantly enhanced both in the absence of
stimulation and in response to TCR triggering in splenic T cells
from Rai2/2 mice compared to their wild-type counterparts
(Fig. 1F). Hence Rai acts as a negative regulator of TCR signaling
beginning from an early step in the cascade, i.e. ZAP-70 activation.
Rai impairs TCR dependent ZAP-70 activation by
interfering with its recruitment to phosphorylated CD3
ZAP-70 activation is initiated by its recruitment to the
phosphorylated ITAMs of the CD3 chain. Full activation requires
its interaction with and phosphorylation by the tyrosine kinase Lck
[20]. To elucidate the mechanisms underlying the inhibition of
TCR dependent ZAP-70 activation by Rai, the interaction of
ZAP-70 with CD3was analyzed in co-immunoprecipitation
experiments in the Jurkat T cell transfectants. As opposed to
control cells, where the basal interaction of ZAP-70 with CD3was
enhanced in response to TCR engagement, no significant increase
was observed in Rai-expressing cells (Fig. 2A). Moreover,
immunoblot analysis with phosphospecific antibodies showed that
the small amount of CD3-bound ZAP-70 was phosphorylated to
barely detectable levels compared to control cells (Fig. 2A). The
interaction of ZAP-70 with Lck was also dramatically impaired in
Rai-expressing cells (Fig. 2B), consistent with the fact that this
event occurs after ZAP-70 recruitment to the activated TCR. On
the other hand, TCR dependent CD3 phosphorylation was
comparable in control and Rai-expressing cells (Fig. 2C). Collec-
tively, these results indicate that Rai acts downstream of CD3
phosphorylation by interfering with ZAP-70 recruitment to the
activated TCR, which results in impaired ZAP-70 activation.
Rai is phosphorylated in response to TCR engagement
and interacts with CD3 and ZAP-70
The modular structure of Rai, together with its phosphoryla-
table tyrosine residues, suggests that Rai may interfere with ZAP-
70 recruitment to phospho-CD3 through the formation of
inhibitory complexes. To address this point Rai-specific immuno-
precipitates were analyzed by immunoblot, using anti-phosphotyr-
osine antibodies. As shown in figure 3A, Rai was found to be
phosphorylated on tyrosine residues in response to TCR
engagement. No phosphorylation was observed when cells were
pretreated with the Lck inhibitor, PP2, indicating that Rai is either
a direct substrate of Lck or the substrate of a kinase, such as ZAP-
70, the activation of which requires Lck.
Three major phosphoproteins, of approximately 20, 70 and
115 kDa, were found to inducibly associate with Rai in response to
TCR engagement. Reprobing the stripped filters with anti-ZAP-
70 antibodies showed that the 70 kDa phosphoprotein corre-
sponds to ZAP-70. Interestingly, Rai also interacts with non-
phosphorylated ZAP-70. This interaction was detectable both in
the absence of stimulation and in PP2-treated cells, albeit at a
reduced extent under these conditions, indicating that it is at least
in part phosphorylation-independent (Fig. 3A). TCR triggering
resulted in an enhancement in ZAP-70 binding to Rai (Fig. 3A).
These results were confirmed in the Rai-expressing JSL1
transfectant (Fig.S1B). Consistent with these data, Rai was found
to constitutively interact with ZAP-70 in T cells from wild-type
mice. This interaction was enhanced in response to TCR
engagement (Fig. 3B). Pull-down assays using the isolated domains
of Rai showed that ZAP-70 strongly interacts with the PTB
domain independently of TCR engagement (Fig. 3C), suggesting
that this domain is responsible to a major extent for the
constitutive association of Rai with ZAP-70. A basal interaction
of ZAP-70 was also observed with the CH1 domain of Rai. This
interaction was however enhanced when the CH1 domain was
phosphorylated in vitro using recombinant Lck, suggesting that the
increase in Rai association with ZAP-70 triggered by TCR
engagement is mediated by the phosphorylated tyrosine residues in
the CH1 domain. At variance, the SH2 domain of Rai failed to
pull down detectable amounts of ZAP-70 (Fig. 3C).
Based on its electrophoretic mobility, the approximately 20 kDa
phosphoprotein which associates with Rai in the activated Jurkat
transfectant (Fig. 3A,D) is likely tyrosine phosphorylated CD3.
This interaction was confirmed in in vitro binding experiments on
lysates of non-stimulated cells, using a GST-CD3 fusion, either
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non-phosphorylated or phosphorylated in vitro with recombinant
Lck (Fig. 3D).
Rai is recruited to the immune synapse
Signaling by the TCR is topologically orchestrated at the
immune synapse. This dynamic interface, that forms when the T
cell encounters an APC carrying cognate antigen, coordinates
positive and negative signals triggered by TCR, CD4/CD8,
costimulatory receptors and integrins engaged by their respective
ligands on the surface of the APC [21]. To understand whether
the association of Rai with CD3 observed biochemically occurs in
the context of immune synapse assembly, Rai was visualized by
immunofluorescence on antigen specific conjugates formed
between Rai-expressing Jurkat cells and Raji B cells loaded with
staphylococcal enterotoxin E (SEE). Conjugates formed in the
absence of SEE were used as controls. As shown in figure 3E
(top), Rai showed a diffuse distribution in control conjugates,
consistent with its cytosolic localization. At variance, in the
Figure 1. Rai dampens TCR signaling. A–E. Immunoblot analysis of ZAP-70 (A), LAT (B), Vav (C), Erk1/2 (D) and JNK (E) phosphorylation in
postnuclear supernatants from control and Rai-expressing Jurkat transfectants activated with anti-CD3 mAb for the indicated times. Phosphospecific
antibodies were used on total postnuclear supernatants to analyze the activation of ZAP-70, Vav, Erk and JNK, while the activation of LAT was
analyzed by immunoblot of LAT specific immunoprecipitates with anti-phosphotyrosine antibodies. The quantification by laser densitometry of the
relative levels of phosphorylation of each of the proteins is shown below the representative immunoblots (n$3; n=2 for P-JNK). F. Immunoblot
analysis of Vav phosphorylation in postnuclear supernatants from splenocytes from wild-type (+/+) or Rai2/2 (2/2) mice activated with anti-CD3
mAb. The quantification by laser densitometry of the relative levels of Vav phosphorylation is shown below the representative immunoblot (n$3).
***p#0.001, **p#0.01*p#0.05.
doi:10.1371/journal.pone.0029899.g001
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presence of SEE a significant enrichment in Rai could be
observed at the contact area with the APC (Fig. 3E, bottom).
Hence Rai is recruited to the immune synapse, where it can
associate with phosphorylated CD3.
Rai interacts with p85 PI-3K
We have previously reported that Rai deficiency in the mouse
results not only in enhanced mitogenic signaling by the TCR, but
also in enhanced survival signaling [14], as assessed by activation
of the pro-survival kinase, Akt, one of the major targets of PI-3K
[22]. Based on the known interaction of Rai with p85, the
regulatory subunit of PI-3K, in neuronal cells [6], we addressed
their potential association in T cells. Immunoblot analysis of Rai-
specific immunoprecipitates showed an interaction of p85 with Rai
in the absence of stimulation, which was modestly enhanced in
response to TCR engagement (Fig. 4A; FigureS1C for the Rai-
expressing JSL1 transfectant). This result was confirmed on splenic
mouse T cells, where the Rai/p85 association was however clearly
potentiated in response to TCR triggering (Fig. 4B). Taken
together with the inhibitory effect of Rai on Akt activation [14] the
results indicate that, although Rai interacts with p85, similar to
neuronal cells, this interaction is not functional to the activation of
PI-3K.
Discussion
While the central function of molecular adapters in coupling cell
surface receptors to multiple intracellular signaling is largely
established, it is only in recent years that their role as negative
regulators has emerged. The mechanisms by which adapters
subserve this function are remarkably diverse. In T cells adapters
such as PAG and SLAP prevent initiation of TCR signaling by
inhibiting the activation of the initiating kinase Lck and by
promoting the degradation of recycling TCR complexes, respec-
tively [23,24]. Others, such as LAT and TRIM, are implicated in
signal extinction by establishing feedback loops through the
recruitment of phosphatases, and by increasing the levels of
surface CTLA-4, respectively [16,23]. The majority of the
adaptors with a negative regulatory function act however as
dampeners of TCR signaling. These include LAX, NTAL and the
Dok family proteins, Dok1, Dok2 and Dok4, as well as p66Shc
[1,16,25]. Interestingly, while in cell models specific steps in TCR
signaling appear to be modulated by individual adapters (e.g. Ras
activation through RasGAP recruitment by Dok1/2, PI3K
activation by LAX), in many instances T cells from mice
genetically deficient for these molecules display a generalized
hyper-reactivity to TCR engagement beginning from the earliest
steps, as documented for LAX, NTAL, Dok1/2 and p66Shc
deficient T cells [26–29]. Hence the precise mechanisms by which
these adaptors dampen TCR signaling is a still open question.
Similar to the latter adaptors, Rai appears to act as a general
dampener of antigen receptor signaling. As previously reported,
Rai deficiency in the mouse results in a hyper-reactivity of
peripheral T and B cells to antigen receptor engagement both in
vitro and in vivo, which eventually leads to the development of
lupus-like autoimmunity [14]. Specifically, this study provided
evidence that Rai modulates the TCR signaling cascade as early as
ZAP-70 and PI-3K activation, which results in impaired Erk and
Akt activation. Here we have addressed the underlying mecha-
nism. The results show that Rai is recruited to phosphorylated
CD3 in response to TCR engagement. The relevance of this
association is underlined by the accumulation of Rai at the
immune synapse. The interaction of Rai with CD3 is dependent
on CD3 phosphorylation, which is not affected by the presence of
Rai. Under these conditions ZAP-70 fails to be effectively
recruited to the TCR, which results in its defective interaction
with Lck and impaired activation. This suggests that Rai may limit
the access of ZAP-70 to phosphorylated CD3, as suggested for
SLAP [30], or alternatively induce its release from the TCR by
establishing an inhibitory interaction. This would provide an
explanation as to why at least part of the ZAP-70 molecules that
interact with Rai are phosphorylated following TCR engagement,
despite the inhibitory activity of Rai on TCR signaling.
Importantly, the pool of Rai participating in a pre-assembled
complex with ZAP-70 in quiescent cells is unlikely to participate in
the interaction with the TCR, as one would expect to observe an
increase in CD3-bound ZAP-70 in response to TCR engagement,
which is not the case. In this scenario, Rai would act as a sink to
sequester ZAP-70 in a state incompetent to associate with CD3.
Alternatively (or additionally), similar to other adaptors that
dampen TCR signaling or establish negative feedback loops, Rai
may exploit its adaptor function to recruit close to the activated
TCR molecules implicated in signal termination, such as protein
tyrosine phosphates (e.g. SHP-2), lipid phosphatases (e.g. SHIP-1)
or ubiquitin ligases (e.g. c-Cbl). Although their molecular mass
made them potential candidates to the approximately 115 kDa
phosphoprotein that coprecipitates with Rai in response to TCR
engagement (Fig. 3), we did not detect any association of Rai with
Figure 2. Rai interferes with ZAP-70 recruitment to phosphor-
ylated CD3. A,B. Immunoblot analysis with anti-ZAP-70 or anti-
phospho-ZAP-70 antibodies of CD3- (A) or Lck- (B) specific immuno-
precipitates from post-nuclear supernatants of the control and Rai-
expressing Jurkat transfectants activated with anti-CD3 mAb for 15 sec.
Control blots of the stripped filters are shown below. C. Immunoblot
analysis with anti-phospho-CD3 mAb and respective control blot of
postnuclear supernatants from the control and Rai-expressing Jurkat
transfectants activated for 1.5 min. The histogram shows the quanti-
fication by laser densitometry of the relative levels of CD3 phosphor-
ylation (n.3).
doi:10.1371/journal.pone.0029899.g002
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Figure 3. Rai forms a complex with CD3 and ZAP-70 and clusters at the immunological synapse. A. Immunoblot analysis with anti-
phospho-tyrosine or anti-ZAP-70 antibodies of Rai-specific immunoprecipitates from post-nuclear supernatants of the Rai-expressing Jurkat
transfectant activated with anti-CD3 mAb for 1.5 min. Where indicated cells were incubated with 20 mM PP2 prior to activation. A control blot of the
stripped filter is shown below. B. Immunoblot analysis with anti-ZAP-70 antibodies of Rai-specific immunoprecipitates from post-nuclear
supernatants of splenocytes from wild-type (+/+) or Rai2/2 (2/2) mice activated with anti-CD3 mAb for 1.5 min. A control blot is shown below. C.
Immunoblot analysis with anti-ZAP-70 antibodies of in vitro binding assays carried out on post-nuclear supernatants of the control Jurkat line using
GST fusion proteins containing the PTB, SH2 or CH1 domain of Rai, the latter either non-phosphorylated or phosphorylated in vitro with recombinant
Lck. Control blots with anti-GST antibodies are shown below. D. Left, Immunoblot analysis with anti-phospho-tyrosine antibodies of Rai-specific
immunoprecipitates from post-nuclear supernatants of the Rai-expressing Jurkat transfectant activated with anti-CD3 mAb for 1.5 min. Right,
Immunoblot analysis with anti-Rai antibodies of in vitro binding assays carried out on post-nuclear supernatants of control or Rai-expressing Jurkat
cells using a GST fusion protein containing the intracellular domain of human CD3, either non-phosphorylated or phosphorylated in vitro with
recombinant Lck. A control blot of the stripped filter is shown below. E. Immunofluorescence analysis of Rai in conjugates of Rai-expressing Jurkat
cells and antigen-pulsed APC (SEE), incubated at 37uC for 15 min. Conjugates formed in the absence of antigen are shown on top part of the panel.
Representative images are shown. No aspecific fluorescence was observed when Rai-expressing cells were immunostained with secondary antibody
alone (not shown).
doi:10.1371/journal.pone.0029899.g003
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either c-Cbl or SHIP-1, nor did we observe an interaction with
SHP-2 (our unpublished results).
In addition to its constitutive interaction with ZAP-70, Rai is
also involved in a constitutive, phosphotyrosine independent
interaction with p85, the regulatory subunit of type I PI-3K. A
similar interaction occurs in neuronal cells, where Rai couples the
Ret receptor to PI-3K activation by forming a pre-assembled
complex with Gab1 and p85, which is recruited to the activated
receptor following ligand binding [12]. The functional outcome of
the association of Rai with p85 is however dramatically different in
neuronal cells and T cells. Recruitment of the Rai/p85 complex to
Ret results in activation of the Akt dependent survival pathway, an
activity which has been confirmed in the in vivo setting of Rai2/2
mice [14]. Conversely, we have previously reported that TCR
dependent Akt activation is enhanced in Rai2/2 T cells, which
correlates with increased cell survival [14]. This inhibitory activity
of Rai on cell survival extends to B cells [14]. Hence Rai promotes
lymphocyte survival in response to antigen receptor signaling, as
opposed to neuronal cells, indicating that its interaction with p85 is
not functional to the activation of p110, the catalytic subunit of
PI3K. Whether, similar to what has been proposed for the adapter
LAX [26], Rai limits PI-3K activation by sequestering p85
remains to be determined. An alternative possibility is that the
attenuation in TCR dependent PI-3K/Akt activation observed in
the presence of Rai is independent of its association with p85 and
rather reflects a generalized defect in TCR signaling resulting from
the inhibitory effect of Rai on the key early event, ZAP-70
activation. The fact that Rai is implicated in opposite biological
outcomes in different cell types is intriguing but not unique. A
similar dual function has been described for example for NTAL,
which acts as a positive regulator of BCR signaling and a negative
regulator of TCR signaling [27,31]. Obviously the cellular context
is likely to be determinant by providing binding partners that,
depending on their specific function, will dictate the final
biological outcome.
To clearly delineate the mechanism of attenuation of TCR
signaling by Rai the interplay with other Shc proteins expressed in
T cells will eventually have to be taken into account. Among these,
all three ShcA isoforms are present in T cells, with the abundantly
expressed p52Shc isoform coupling the TCR to the Ras and Rho
small GTPases and the less abundant p66Shc isoform dampening
TCR signaling, similar to Rai. Whether Rai cooperates with
p66Shc in this function remains to be understood. Nevertheless,
the function of Rai appears not to be redundant, as shown by the
immune alterations in Rai2/2 mice. This notion is further
supported by the differences in the pathological features in mice
lacking Rai and p66Shc, which include membranous autoimmune
glomerulonephritis and alopecia as unique features of p66Shc2/2
mice [29]. Another important consideration is that, while both Rai
and p66Shc attenuate TCR signaling by intefering with the initial
steps of the cascade, it cannot be ruled out at this stage that
individual signaling mediators might be differentially modulated
by the two adapters. Specific components of the TCR signaling
cascade have been selectively implicated in commitment of CD4+
T cell to develop to a specific helper subset, as shown for Akt1 and
Vav1 in the development Th1 and Th2 effectors, respectively
[32,33]. Addressing the impact of Rai and p66Shc deficiency on
helper T cell polarization may provide insight into the complex
process that underlies this fundamental developmental decision.
Materials and Methods
Cells and mice
Cell lines included the human T-lymphoma Jurkat line [34], the
Shc-deficient Jurkat variant JSL1 [15] and the human Raji B cell
line [35]. Jurkat and Raji cells were a generous gift of Dr. D.
Boraschi (National Research Council, Pisa, Italy). Stable Jurkat
and JSL-1 transfectants were generated using either an expression
construct encoding p52Rai or empty vector.
4–6 months old Rai2/2 mice backcrossed in C57BL/6, as well
as control age- and sex-matched C57BL/6 mice (Harlan, Italia),
were used in this study. All mice were maintained in the animal
facility of the University of Siena (Siena, Italy) and the IEO-IFOM
(Milan, Italy). Mice were housed in a light (07:00 to 19:00) and
temperature (18uC–22uC) controlled environment, and food
(Global diet 2018; Mucedola, Settimo Milanese, Italy) and water
were provided for consumption ad libitium. All animal experiments
were carried out in agreement with the Guiding Principles for
Research Involving Animals and Human Beings and approved by
the local ethical committee of the University of Siena, Italy
(protocol approval 31 March 2008). Mice were sacrified by
cervical dislocation, and all efforts were made to minimize
suffering.
Antibodies and reagents, GST fusions
Phosphospecific antibodies recognizing the active forms of ZAP-
70, Erk1/2 and JNK were from Cell Signaling Technology; anti-
phospho-CD3f from Santa Cruz Biotechnology (Santa Cruz),
anti-phospho-Vav from Biosource (Camarillo). The anti-Rai CH1
mAb was from Becton-Dickinson Biosciences; mAbs against Erk2
and CD3f, as well as anti-LAT polyclonal antibodies, were from
Santa Cruz Biotechnology; anti-phosphotyrosine, anti-Vav, anti-
ZAP-70 and anti-LAT mAbs, as well as anti-Lck and anti-Shc
polyclonal antibodies, from Upstate Biotechnology Inc; the anti-
Figure 4. Rai interacts with p85 PI3K. A,B. Immunoblot analysis with anti-p85 antibodies of Rai-specific immunoprecipitates from post-nuclear
supernatants of the Rai-expressing Jurkat transfectant (A) or of splenocytes from wild-type (+/+) or Rai2/2 (2/2) mice (B), activated with anti-CD3
mAb for the indicated times. Control blots of the stripped filters are shown below.
doi:10.1371/journal.pone.0029899.g004
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actin mAb from Millipore. IgG antibodies from OKT3 (mouse
anti-human) and 145-2c11 (hamster anti-mouse CD3) hybridoma
supernatants were purified on Mabtrap (Amersham Biosciences,
GE Healthcare Life Sciences Italia) and titrated by flow cytometry.
Both hybridomas were obtained from the Americal Type Culture
Collection (Manassas, USA). PP2 was purchased from Calbiochem
(Merck KGaA, Darmstadt, Germany).
The GST fusion containing the cytosolic domain of CD3 was
previously described [36]. The cDNAs encoding the PTB, CH1
and SH2 domains of human Rai were inserted into the bacterial
expression plasmid pGEX6P. The recombinant fusion proteins, as
well as control GST, were affinity purified on GSH-Sepharose
(GE Healthcare) from bacterial cultures incubated for 4 h at 37uC
with 0.25 mM isopropyl-b-D-thiogalactopyranoside and lysed by
sonication in PBS-1% Triton X-100.
Cell activation and lysis, immunoprecipitations,
immunoblots and in vitro binding assays
Jurkat transfectants (56106 cells/sample) or splenocytes from
control or Rai2/2 mice (106106/sample) were activated by cross-
linking the TCR/CD3 complex in solution at 37uC using anti-
CD3 mAb and secondary antibodies. Cells were lysed in 3% or
1% (v/v) Triton X-100 in 20 mM Tris-HCl (pH 8), 150 mM
NaCl (in the presence of 0.2 mg Na orthovanadate/ml, 1 mg/ml
pepstatin, leupeptin and aprotinin, and 10 mM phenylmethylsul-
fonyl fluoride). Postnuclear supernatants were resolved by SDS-
PAGE and transferred to nitrocellulose. Alternatively, postnuclear
supernatants from 50–1006106 cells/sample were immunopre-
cipitated using the appropriate polyclonal or monoclonal antibod-
ies and protein A Sepharose (GE Healthcare) or anti-mouse IgG
(whole molecule)-Agarose (Sigma Aldrich, Milan, Italy), respec-
tively. Immunoblots were carried out using peroxidase-labeled
secondary antibodies (GE Healthcare) and a chemiluminescence
detection kit (Bio-rad Laboratories Inc, Milan, Italy). Immunoblots
were scanned using a laser densitometer (Duoscan T2500) and
quantified using the ImageQuant 5.0 software (GE Healthcare).
Pre-stained molecular weight markers were purchased from Lonza
Milano srl (Italy).
In vitro-binding assays were carried using the GST-tagged
proteins as described [36] on GSH-Sepharose precleared post-
nuclear supernatants from 16107 cells/sample, either activated or
not and lysed in 1% Triton X-100 in the presence of protease
inhibitors. Where required, GST-CH1 (Rai) and GST-CD3f were
previously phosphorylated in vitro in 20 ml of 20 mM Tris-HCl
(pH 7.4), 10 mM MgCl2, 10 mM MnCl2, 50 mM ATP for 20 min
using recombinant Lck (EMD Millipore, Merck KgaA, Darm-
stadt, Germany). The effectiveness of phosphorylation was
checked by immunoblot with anti-phosphotyrosine antibodies.
Immunofluorescence microscopy
Control or p52Rai-expressing Jurkat cells (1.56105 cells/4 ml
PBS) were fixed with methanol and processed for immunofluo-
rescence microscopy as previously described [37]. For the immune
synapse experiments, Raji cells (used as APCs) were pulsed for 2 h
with 10 mg/ml SEE and labeled with 10 mM Cell Tracker Blue for
20 min. APC were washed, mixed with Jurkat cells (1:1) for
15 min and plated on polylysine-coated wells of diagnostic
microscope slides (Erie Scientific Company, Portsmouth, USA).
Cells were allowed to adhere for 15 min and then processed as
described [37]. Antigen-independent conjugates were obtained by
mixing T cells and APCs in the absence of SEE. Following
fixation, samples were washed 5 min in PBS and incubated for 1 h
at RT with anti-Rai mAb. After washing in PBS, samples were
incubated for 1 h at RT with Alexa Fluor 488-labeled secondary
antibodies. Confocal microscopy was carried out on a Zeiss
LSM700 using a 636 objective. Z series of optical sections were
performed at 0.5 mm increments. Images were acquired with
pinholes opened to obtain optical sections of 0.6 mm thick.
Detectors were set to detect an optimal signal below the saturation
limits. Images were processed with Zen 2009 image software (Carl
Zeiss, Jena, Germany).
Statistical analyses
Values of specified groups were compared using the Student t
test statistics, unpaired, provided by the Excel application. A level
of p,0.05 was considered statistically significant.
Supporting Information
Figure S1 A. Immunoblot analysis with anti-Rai, anti-Shc and
anti-actin antibodies of postnuclear supernatants from Jurkat and
JSL1 cells stably transfected with either empty vector (ctr) or the
same vector encoding the p52 kDa isoform of Rai. B,C.
Immunoblot analysis with anti-ZAP-70 (B) or anti-p85 (C)
antibodies of Rai-specific immunoprecipitates from post-nuclear
supernatants of the Rai-expressing JSL1 transfectant activated
with anti-CD3 mAb for 1.5 min. Control blots of the stripped
filters are shown below.
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